Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Martine, Berlière"'
Autor:
Françoise Derouane, Manon Desgres, Camilla Moroni, Jérôme Ambroise, Martine Berlière, Mieke R. Van Bockstal, Christine Galant, Cédric van Marcke, Marianela Vara-Messler, Stefan J. Hutten, Jos Jonkers, Larissa Mourao, Colinda L. G. J. Scheele, Francois P. Duhoux, Cyril Corbet
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-19 (2024)
Abstract Background Neoadjuvant chemotherapy (NAC) is the standard of care for patients with early-stage triple negative breast cancers (TNBC). However, more than half of TNBC patients do not achieve a pathological complete response (pCR) after NAC,
Externí odkaz:
https://doaj.org/article/cbcb7ddcc69b4cbbb96f42be1600415c
Autor:
Pierrick Godin, Francois P. Duhoux, Filomena Mazzeo, Michel Rojas, Emmanuel Bollue, Aline François, Christine Galant, Julien Coulie, Maude Coyette, Audrey Lentini, Yannick Deswisen, Vasiliki Perlepe, Latifa Fellah, Isabelle Leconte, Martine Berlière
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 238-244 (2022)
Epidemiological studies suggest that around 10% of breast cancers are due to hereditary predisposition. The risk of cancer is exponentially increased in patients harboring BRCA1 or BRCA2 mutations. Cumulative breast cancer risk by age 80 is estimated
Externí odkaz:
https://doaj.org/article/f730f32689594f049acf296d3f13aa4d
Autor:
Noureddine Hassayoune, MD, Mina Mhallem Gziri, MD, PhD, Audrey Lentini, MD, Theodoros Chrelias, MD, Jennifer Hammer, MD, Martine Berlière, MD, PhD, Benoît Lengelé, MD, PhD, FRCS, Maude Coyette, MD
Publikováno v:
JPRAS Open, Vol 29, Iss , Pp 65-70 (2021)
Summary: Gestational gigantomastia (GGM) is a rare condition characterized by a massive overgrowth of breast tissue during pregnancy. Surgical sanction may be required when conservative measures fail. In this study, we report the case of a 29-year-ol
Externí odkaz:
https://doaj.org/article/649fdbddf7db40e390f3400c1293d951
Autor:
Cédric Van Marcke, Raphaël Helaers, Anne De Leener, Ahmad Merhi, Céline A. Schoonjans, Jérôme Ambroise, Christine Galant, Paul Delrée, Françoise Rothé, Isabelle Bar, Elsa Khoury, Pascal Brouillard, Jean-Luc Canon, Peter Vuylsteke, Jean-Pascal Machiels, Martine Berlière, Nisha Limaye, Miikka Vikkula, François P. Duhoux
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-13 (2020)
Abstract Background Multigene panels are routinely used to assess for predisposing germline mutations in families at high breast cancer risk. The number of variants of unknown significance thereby identified increases with the number of sequenced gen
Externí odkaz:
https://doaj.org/article/44b3c35783f64909bdc3137b3da359fb
Autor:
Alix Devaux, Gabriela Beniuga, Claire Quaghebeur, Stéphanie Henry, Mieke Van Bockstal, Christine Galant, Paul Delrée, Jean-Luc Canon, Brigitte Honhon, Dominique Korman, Vincent Verschaeve, Christophe Lonchay, Sarah Lefevre, Lionel D’Hondt, Martine Berlière, Sophie Delmarcelle, Jean-Michel Mine, Timour Willems, Gebhard Müller, Nathalie Myant, Isabelle Bar, Sandy Haussy, Pierre G. Coulie, François P. Duhoux, Javier Carrasco
Publikováno v:
Cancer Research. 83:P4-07
Background: Neoadjuvant association of immune checkpoints inhibitors (ICI) and dose dense chemotherapy is promising for triple negative breast cancers (TNBC). However, response rates vary from one study to another. Timing, best chemotherapy partner a
Publikováno v:
International journal of surgical pathology.
Silicone breast implants are frequently used for breast augmentation for cosmetic purposes, as well as for breast reconstruction after prophylactic or therapeutic mastectomy. Silicone lymphadenopathy is a well-known complication of silicone breast im
Autor:
Jennifer Hammer, Theodoros Chrelias, Martine Berlière, Mina Mhallem Gziri, Benoît Lengelé, Noureddine Hassayoune, Audrey Lentini, Maude Coyette
Publikováno v:
JPRAS Open
JPRAS open, Vol. 29, no.1, p. 65-70 (2021)
JPRAS Open, Vol 29, Iss, Pp 65-70 (2021)
JPRAS open, Vol. 29, no.1, p. 65-70 (2021)
JPRAS Open, Vol 29, Iss, Pp 65-70 (2021)
Summary: Gestational gigantomastia (GGM) is a rare condition characterized by a massive overgrowth of breast tissue during pregnancy. Surgical sanction may be required when conservative measures fail. In this study, we report the case of a 29-year-ol
Autor:
François Duhoux, Latifa Fellah, Claudia Maria Stanciu-Pop, Christine Galant, Mieke R. Van Bockstal, Marie-Cécile Nollevaux, Martine Berlière
Publikováno v:
Virchows Archiv, Vol. 479, no. 1, p. 33-43 (2021)
Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease in terms of morphological characteristics, protein expression profiles, genetic abnormalities, and potential for progression. Molecular heterogeneity has been extensively studie
Autor:
Alberta Ferrari, Lucia Del Mastro, Albert Grinshpun, Amir Sonnenblick, Sileny Han, Matteo Lambertini, Philip D. Poorvu, Jose Alejandro Perez-Fidalgo, Fedro A. Peccatori, Rossella Graffeo, Riccardo Ponzone, Hatem A. Azim, Shani Paluch-Shimon, Luca Livraghi, Luis Augusto Teixeira, Olivier Caron, Maria Vittoria Dieci, Anne-Sophie Hamy, Michail Ignatiadis, Estela Carrasco, Laura De Marchis, Gianmaria Miolo, Claire Senechal, Martine Berlière, Christine Rousset-Jablonski, Katarzyna Pogoda, Octavi Cordoba, Cynthia Villarreal-Garza, Anna Zingarello, Helena Luna Pais, Laura Cortesi, Claire Saule, Lieveke Ameye, Florian Clatot, Maria Del Pilar Estevez-Diz, Marianne Paesmans, Ann H. Partridge
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
PURPOSE Young women with germline BRCA mutations have unique reproductive challenges. Pregnancy after breast cancer does not increase the risk of recurrence; however, very limited data are available in patients with BRCA mutations. This study investi
Publikováno v:
American journal of clinical pathology, Vol. 154, no.5, p. 596-609 (2020)
ObjectivesSince most patients with ductal carcinoma in situ (DCIS) of the breast are treated upon diagnosis, evidence on its natural progression to invasive carcinoma is limited. It is estimated that around half of the screen-detected DCIS lesions wo